iBio, Inc. announced that on January 20, 2023, the Board of Directors appointed Mr. Felipe Duran, to the position of Interim Chief Financial Officer, effective as of February 13, 2023. ? Mr. Duran, age 43, has served as the Company's Vice President of Financial Planning and Analysis (FP&A) since April 2021.

Previously, Mr. Duran served as the Executive Director (CFO), of Lupin Latin America, a subsidiary of Lupin Pharmaceuticals, from May 2016 to May 2021. Prior to joining Lupin Pharmaceuticals, he held numerous strategy positions at Teva Pharmaceuticals in both its growth markets and Latin America offices. Mr. Duran also worked as a Manager, FP&A for both Bupa and Noven Pharmaceuticals.

Mr. Duran holds a B.A. in Finance and an M.B. A from the University of Miami.